Bobo Donald E Jr's Form 4 filing
Edwards Lifesciences CorpEW · filed Dec 12, 2025
- Accession no.
- 0001225208-25-009935
- Filed
- Dec 12, 2025
- Trade date
- Dec 12, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $953.7K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bobo Donald E JrCIK 0001196661 | Officer (CVP,Strategy/Corp Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | SSaleDisposed | −5,486.12 | $83.79 | −$459,681.99 | 44,870.25 | Direct | |
| Dec 12, 2025 | Common Stock | SSaleDisposed | −5,900 | $83.74 | −$494,066 | 38,970.25 | Direct | |
| Dec 12, 2025 | Common Stock | GGiftDisposed | −7,100 | $0.00 | $0 | 31,870.25 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.